Register

COURSE DESCRIPTION: 
Please join us for a conference on Sepsis and Septic Shock - A Decade of Evidence with Aashish Neupane, M.D. Dr. Neupane will define and explain the updated Sepsis 3.0 criteria, including key differences from previous definitions, interpret and evaluate the clinical utility of emerging diagnostic tests and biomarkers for early detection and monitoring of sepsis, and assess and monitor tissue perfusion and microcirculatory function in septic patients to guide therapeutic interventions.

TARGET AUDIENCE:
Internal Medicine Physicians, Pharmacists, Physician Assistants, Residents,  Advanced Practice Registered Nurses, and all other interested healthcare providers

LEARNING OBJECTIVES:

• Define and explain the updated Sepsis 3.0 criteria, including key differences from previous definitions.
• Interpret and evaluate the clinical utility of emerging diagnostic tests and biomarkers for early detection and monitoring of sepsis.
• Apply current evidence-based guidelines to develop and implement appropriate management plans for patients with sepsis.
• Assess and monitor tissue perfusion and microcirculatory function in septic patients to guide therapeutic interventions.

FACULTY AND DISCLOSURES:

Aashish Neupane, MD.
Critical Care Medicine
Baptist Health Boca Raton Regional Hospital Bethesda East Hospital
Clinical Affiliate Associate Professor 
Charles E. Schmidt College of Medicine
Florida Atlantic University
Boca Raton, Florida

Aashish Neupane, M.D., faculty for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will include off-label or unapproved product usage.

John F. Rubin, M.D., FACP, director of this educational activity, has indicated that he is a shareholder in AstraZeneca and Bristol-Myers Squibb. All of the relevant financial relationships listed for this individual have been mitigated.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-1296402, by the Florida Boards of Medicine, Podiatry, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Laboratory Personnel, Athletic Trainers and Respiratory Techs. Baptist Health South Florida CE Broker Provider #50-182.